Lawson, P. A. et al.,Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prévot 1938DOI10.1016/j.anaerobe.2016.06.008
(en) J. Collins, C. Robinson, H. Danhof et C. W. Knetsch, « Dietary trehalose enhances virulence of epidemic Clostridium difficile », Nature, (DOI10.1038/nature25178).
(en) Stefano Di Bella, Paolo Ascenzi, Steven Siarakas et Nicola Petrosillo, « Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects », Toxins, vol. 8, no 5, , p. 134 (ISSN2072-6651, PMID27153087, PMCIDPMC4885049, DOI10.3390/toxins8050134, lire en ligne, consulté le )
Mohamad-Gabriel Alameh, Alexa Semon, Nile U. Bayard et Yi-Gen Pan, « A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection », Science, vol. 386, no 6717, , p. 69–75 (PMID39361752, PMCIDPMC11719173, DOI10.1126/science.adn4955, lire en ligne, consulté le )
(en) Lancaster JW, Matthews SJ, « Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections », Clin Ther, vol. 34, no 1, , p. 1-13 (PMID22284993, DOI10.1016/j.clinthera.2011.12.003)modifier
(en) Stefano Di Bella, Paolo Ascenzi, Steven Siarakas et Nicola Petrosillo, « Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects », Toxins, vol. 8, no 5, , p. 134 (ISSN2072-6651, PMID27153087, PMCIDPMC4885049, DOI10.3390/toxins8050134, lire en ligne, consulté le )
(en) Stefano Di Bella, Paolo Ascenzi, Steven Siarakas et Nicola Petrosillo, « Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects », Toxins, vol. 8, no 5, , p. 134 (ISSN2072-6651, PMID27153087, PMCIDPMC4885049, DOI10.3390/toxins8050134, lire en ligne, consulté le )
(en) Stefano Di Bella, Paolo Ascenzi, Steven Siarakas et Nicola Petrosillo, « Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects », Toxins, vol. 8, no 5, , p. 134 (ISSN2072-6651, PMID27153087, PMCIDPMC4885049, DOI10.3390/toxins8050134, lire en ligne, consulté le )
(en) Brown,K, « Hospital Ward Antibiotic Prescribing and the Risks of Clostridium difficile Infection. », JAMA Intern Med, (lire en ligne)
Mohamad-Gabriel Alameh, Alexa Semon, Nile U. Bayard et Yi-Gen Pan, « A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection », Science, vol. 386, no 6717, , p. 69–75 (PMID39361752, PMCIDPMC11719173, DOI10.1126/science.adn4955, lire en ligne, consulté le )
(en) Lancaster JW, Matthews SJ, « Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections », Clin Ther, vol. 34, no 1, , p. 1-13 (PMID22284993, DOI10.1016/j.clinthera.2011.12.003)modifier
Mohamad-Gabriel Alameh, Alexa Semon, Nile U. Bayard et Yi-Gen Pan, « A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection », Science, vol. 386, no 6717, , p. 69–75 (PMID39361752, PMCIDPMC11719173, DOI10.1126/science.adn4955, lire en ligne, consulté le )
(en) Lancaster JW, Matthews SJ, « Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections », Clin Ther, vol. 34, no 1, , p. 1-13 (PMID22284993, DOI10.1016/j.clinthera.2011.12.003)modifier